FR2715937B1 - - Google Patents

Info

Publication number
FR2715937B1
FR2715937B1 FR9401532A FR9401532A FR2715937B1 FR 2715937 B1 FR2715937 B1 FR 2715937B1 FR 9401532 A FR9401532 A FR 9401532A FR 9401532 A FR9401532 A FR 9401532A FR 2715937 B1 FR2715937 B1 FR 2715937B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9401532A
Other languages
French (fr)
Other versions
FR2715937A1 (fr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR9401532A priority Critical patent/FR2715937A1/fr
Application filed filed Critical
Priority to JP52042695A priority patent/JP3611856B2/ja
Priority to DE69533863T priority patent/DE69533863T2/de
Priority to PCT/FR1995/000142 priority patent/WO1995021256A1/fr
Priority to NZ279855A priority patent/NZ279855A/en
Priority to FI954699A priority patent/FI954699A7/fi
Priority to AT95420027T priority patent/ATE285475T1/de
Priority to US08/384,137 priority patent/US5871996A/en
Priority to DE0674004T priority patent/DE674004T1/de
Priority to AU17114/95A priority patent/AU704440B2/en
Priority to CA002141907A priority patent/CA2141907A1/fr
Priority to ES95420027T priority patent/ES2233936T3/es
Priority to EP95420027A priority patent/EP0674004B1/fr
Priority to US08/471,969 priority patent/US5871745A/en
Priority to US08/471,724 priority patent/US5800980A/en
Priority to US08/470,006 priority patent/US5962217A/en
Publication of FR2715937A1 publication Critical patent/FR2715937A1/fr
Priority to NO953925A priority patent/NO953925L/no
Application granted granted Critical
Publication of FR2715937B1 publication Critical patent/FR2715937B1/fr
Priority to US09/133,411 priority patent/US6342383B1/en
Priority to US09/200,990 priority patent/US6184025B1/en
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/10021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
FR9401532A 1899-02-04 1994-02-04 Virus MSRV1 et MSRV2 associés ensemble à la sclérose en plaques et leurs constituants nucléiques. Granted FR2715937A1 (fr)

Priority Applications (19)

Application Number Priority Date Filing Date Title
FR9401532A FR2715937A1 (fr) 1994-02-04 1994-02-04 Virus MSRV1 et MSRV2 associés ensemble à la sclérose en plaques et leurs constituants nucléiques.
ES95420027T ES2233936T3 (es) 1994-02-04 1995-02-06 Virus msrv1 asociado a la esclerosis en placas, sus constituyentes nucleicos y sus aplicaciones.
PCT/FR1995/000142 WO1995021256A1 (fr) 1994-02-04 1995-02-06 Virus msrv1 et agent pathogene et/ou infectant msrv2 associes a la sclerose en plaques, leurs constituants nucleiques et leurs applications
NZ279855A NZ279855A (en) 1994-02-04 1995-02-06 Msrv1 and msrv2 pathogenic and/or infectious agents associated with ms, nucleic acids encoding them and diagnostic and therapeutic applications
FI954699A FI954699A7 (fi) 1994-02-04 1995-02-06 MSRV1-virus ja multippeliskleroosiin liittyvä patogeeninen ja/tai infe ktoiva MSRV2-agenssi, niiden nukleiinihappokomponentteja ja niiden sov ellutuksia
AT95420027T ATE285475T1 (de) 1994-02-04 1995-02-06 Msrv1 virus der mit multipler sklerose verbunden ist, seine nukleären bestandteile und verwendungen
US08/384,137 US5871996A (en) 1994-02-04 1995-02-06 Retrovirus agents MSRV1 and MSRV2 associated with multiple sclerosis
DE0674004T DE674004T1 (de) 1994-02-04 1995-02-06 MSRV1 Virus und ansteckender und/oder krankheitserregender MSRV2, die mit Multipler Sklerose verbunden sind, ihre nukleären Bestandteile und Verwendungen.
AU17114/95A AU704440B2 (en) 1994-02-04 1995-02-06 MSRV1 virus and MSRV2 pathogenic and/or infectious agent associated with multiple sclerosis, nucleic acid components and applications of same
EP95420027A EP0674004B1 (fr) 1994-02-04 1995-02-06 Virus MSRV1 associé à la Sclérose en Plaques, ses constituants nucléiques et leurs applications
JP52042695A JP3611856B2 (ja) 1994-02-04 1995-02-06 多発性硬化症に関与するｍｓｒｖ１ウイルスおよびｍｓｒｖ２病因性及び／又は感染性の作因、核酸成分およびその応用
DE69533863T DE69533863T2 (de) 1994-02-04 1995-02-06 MSRV1 Virus der mit Multipler Sklerose verbunden ist, seine nukleären Bestandteile und Verwendungen
CA002141907A CA2141907A1 (fr) 1994-02-04 1995-02-06 Virus msrv1 et agent pathogene et/ou infectant msrv2 associes a la sclerose en plaques, leurs constituants nucleiques et leurs applications
US08/471,969 US5871745A (en) 1994-02-04 1995-06-06 Multiple sclerosis related virus
US08/471,724 US5800980A (en) 1899-02-04 1995-06-06 Detection of MSRV1 virus and MSRV2 pathogen and/or infective agent associated with multiple sclerosis, by nucleic acid hybridization
US08/470,006 US5962217A (en) 1994-02-04 1995-06-06 MSRV1 virus and MSRV2 pathogen and/or infective agent associated with multiple sclerosis, and biopolymer constituents thereof
NO953925A NO953925L (no) 1994-02-04 1995-10-03 MSRV1-virus og MSRV2-patogent og/eller infeksiöst middel forbundet med multippel sklerose, nukleinsyrekomponenter og anvendelse av disse
US09/133,411 US6342383B1 (en) 1994-02-04 1998-08-13 Cell lines and viral isolates associated with multiple sclerosis
US09/200,990 US6184025B1 (en) 1994-02-04 1998-11-30 Viral isolates associated with multiple sclerosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9401532A FR2715937A1 (fr) 1994-02-04 1994-02-04 Virus MSRV1 et MSRV2 associés ensemble à la sclérose en plaques et leurs constituants nucléiques.

Publications (2)

Publication Number Publication Date
FR2715937A1 FR2715937A1 (fr) 1995-08-11
FR2715937B1 true FR2715937B1 (enrdf_load_stackoverflow) 1997-02-14

Family

ID=9459973

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9401532A Granted FR2715937A1 (fr) 1899-02-04 1994-02-04 Virus MSRV1 et MSRV2 associés ensemble à la sclérose en plaques et leurs constituants nucléiques.

Country Status (1)

Country Link
FR (1) FR2715937A1 (enrdf_load_stackoverflow)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2762601B3 (fr) 1997-04-29 1999-06-04 Bio Merieux Polypeptide capable de reagir avec les anticorps de patients atteints de sclerose en plaques et utilisations
FR2765588A1 (fr) 1997-07-07 1999-01-08 Bio Merieux Materiel nucleique retroviral et fragments nucleotidiques notamment associes a la sclerose en plaques et/ou la polyarthrite rhumatoide, a des fins de diagnostic, prophylactiques et therapeutiques

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK173091D0 (da) * 1991-10-11 1991-10-11 Schleroseforeningen The Danish Biologisk materiale
FR2689520B1 (fr) * 1992-04-03 1996-07-19 Bio Merieux Procede et milieu de culture pour l'obtention de cellules infectees par un virus associe a la sclerose en plaques.
ES2257734T3 (es) * 1992-05-18 2006-08-01 Genentech, Inc. Activacion de los receptores de oligomerizacion por medio de los ligandos de receptores fusionados.
GB9310657D0 (en) * 1993-05-24 1993-07-07 Univ London Retrovirus

Also Published As

Publication number Publication date
FR2715937A1 (fr) 1995-08-11

Similar Documents

Publication Publication Date Title
TW284868B (enrdf_load_stackoverflow)
EP0669395A3 (enrdf_load_stackoverflow)
EP0669187A3 (enrdf_load_stackoverflow)
EP0671407A3 (enrdf_load_stackoverflow)
TW290485B (enrdf_load_stackoverflow)
TW274171B (enrdf_load_stackoverflow)
TW275581B (enrdf_load_stackoverflow)
EP0667627A3 (enrdf_load_stackoverflow)
FR2715937B1 (enrdf_load_stackoverflow)
FR2724228B1 (enrdf_load_stackoverflow)
CU22453A3 (enrdf_load_stackoverflow)
IN189689B (enrdf_load_stackoverflow)
IN190992B (enrdf_load_stackoverflow)
IN189499B (enrdf_load_stackoverflow)
IN181525B (enrdf_load_stackoverflow)
ECSDI940198S (enrdf_load_stackoverflow)
DK40195A (enrdf_load_stackoverflow)
ECSDI940187S (enrdf_load_stackoverflow)
ECSDI940192S (enrdf_load_stackoverflow)
ECSMU940034U (enrdf_load_stackoverflow)
EP0666274A3 (enrdf_load_stackoverflow)
CN3029313S (enrdf_load_stackoverflow)
EP0668111A3 (enrdf_load_stackoverflow)
EP0668066A3 (enrdf_load_stackoverflow)
EP0667713A3 (enrdf_load_stackoverflow)

Legal Events

Date Code Title Description
ST Notification of lapse